Dexamethasone treatment failed to demonstrate noninferiority to surgery for chronic subdural hematoma and was associated with more complications and a greater risk of later surgery, according to ...

PHOENIX -- For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the Onyx liquid embolic ...

The treatment of a subdural hematoma received a major boost with three new randomized controlled trials all showing large and significant benefits of a new embolization process done as an endovascular ...

STATEN ISLAND, N.Y. — A neurosurgeon at Richmond University Medical Center has perfected a minimally invasive surgical procedure to eliminate chronic subdural hematomas — reducing the chance of ...

The Society of Neurolnterventional Surgery (SNIS) is acknowledging middle meningeal artery embolization (MMAE) as a beneficial adjunctive treatment for chronic subdural hematoma in light of new ...

A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed no improvement in functional outcomes in patients with acute subdural hematoma who ...

Onyx is a liquid embolic agent that is injected into an artery to occlude blood flow. In subdural hematoma, it is used to block the MMA, stopping the chronic oozing of blood into the subdural space.

A dramatic, threefold reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, according to ...

A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, ...

In this multicenter, open-label, controlled, noninferiority trial, we randomly assigned symptomatic patients with chronic subdural hematoma in a 1:1 ratio to a 19-day tapering course of dexamethasone ...